Panitumumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Panitumumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about GlobalPharmacyMeds.to
List of countries where we can ship Panitumumab:
Latest news releases on Panitumumab:
Panitumumab , formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and ...
Vectibix® (panitumumab) Injection for Intravenous Use Subsequent to the development of severe dermatologic toxicities, infectious complications, including sepsis, septic
BackgroundPatients with metastatic colorectal cancer that harbors KRAS mutations in exon 2 do not benefit from anti–epidermal growth factor receptor (EGFR) therapy.
Vectibix treats metastatic colorectal cancer that has progressed after treatment with other chemotherapy. Learn about side effects, interactions and indications.
Learn about Vectibix® (panitumumab), a treatment option for wild-type RAS metastatic colorectal cancer. See Prescribing Information and Boxed Warning.
Notes: The three weekly panitumumab regimen has been used in select patients. Drug status: Panitumumab is PBS authority. Cost: ~ $3,690 per cycle "How this cost is ...
Each mL of concentrate contains 20 mg panitumumab. Each single-use vial contains either 100 mg of panitumumab in 5 mL, or 400 mg of panitumumab in 20 mL.
PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat ...
Our findings show that panitumumab is non-inferior to cetuximab and that these agents provide similar overall survival benefit in this population of patients. Both ...